• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嘌呤代谢异常所致免疫缺陷疾病:临床特征与分子机制

Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.

作者信息

Mitchell B S, Kelley W N

出版信息

Ann Intern Med. 1980 Jun;92(6):826-31. doi: 10.7326/0003-4819-92-6-826.

DOI:10.7326/0003-4819-92-6-826
PMID:6247948
Abstract

Deficiencies of two enzymes that catalyze sequential reactions in the purine catabolic pathway have been causally associated with immunodeficiency states. Adenosine deaminase (ADA) deficiency results in severe combined immunodeficiency disease, while purine nucleoside phosphorylase (PNP) deficiency results in an isolated T-cell defect. Recent work in this area has provided major new insights into the molecular pathology of these syndromes. Deoxyadenosine and deoxyguanosine, substrates that accumulate in ADA and deoxyguanosine, substrates that accumulate in ADA and PNP deficiency, respectively, appear to be selectively phosphorylated by lymphoid cells to the corresponding deoxynucleoside triphosphate, resulting in inhibition of DNA synthesis in these cells. Both deoxynucleosides are far more toxic to cultured T lymphoblasts than to B lymphoblasts. Adenosine and deoxyadenosine may have additional lymphotoxic effects mediated by inhibition of essential methylation reactions. These observations help to explain the immunologic manifestations of ADA and PNP deficiency. Perhaps more important, they lay the foundation for the use of deoxynucleosides or enzyme inhibitors, or both, as selective immunosuppressive and chemotherapeutic agents.

摘要

催化嘌呤分解代谢途径中连续反应的两种酶的缺陷已被证实与免疫缺陷状态存在因果关系。腺苷脱氨酶(ADA)缺乏会导致严重联合免疫缺陷病,而嘌呤核苷磷酸化酶(PNP)缺乏会导致单纯T细胞缺陷。该领域最近的研究为这些综合征的分子病理学提供了重要的新见解。脱氧腺苷和脱氧鸟苷分别是在ADA和PNP缺乏时积累的底物,它们似乎被淋巴细胞选择性地磷酸化为相应的三磷酸脱氧核苷,从而抑制这些细胞中的DNA合成。这两种脱氧核苷对培养的T淋巴母细胞的毒性远比对B淋巴母细胞的毒性大。腺苷和脱氧腺苷可能通过抑制必需的甲基化反应而具有额外的淋巴细胞毒性作用。这些观察结果有助于解释ADA和PNP缺乏的免疫学表现。也许更重要的是,它们为使用脱氧核苷或酶抑制剂,或两者兼用,作为选择性免疫抑制剂和化疗药物奠定了基础。

相似文献

1
Purinogenic immunodeficiency diseases: clinical features and molecular mechanisms.嘌呤代谢异常所致免疫缺陷疾病:临床特征与分子机制
Ann Intern Med. 1980 Jun;92(6):826-31. doi: 10.7326/0003-4819-92-6-826.
2
Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏时的脱氧核糖核苷毒性:对新型免疫抑制剂开发的启示
Ciba Found Symp. 1978(68):115-33. doi: 10.1002/9780470720516.ch8.
3
[Primary immunodeficiencies and purine metabolism].[原发性免疫缺陷与嘌呤代谢]
Rev Clin Esp. 1985 Oct;177(6):247-53.
4
ADA and PNP deficiencies: how it all began.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏症:一切的开端
Ann N Y Acad Sci. 1985;451:1-8. doi: 10.1111/j.1749-6632.1985.tb27090.x.
5
Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.腺苷脱氨酶和嘌呤核苷磷酸化酶的基因缺陷及其对白血病治疗的影响。
Curr Top Hematol. 1983;4:1-35.
6
Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.遗传性酶缺乏症和免疫缺陷:腺苷脱氨酶(ADA)和嘌呤核苷磷酸化酶(PNP)缺乏症。
Clin Immunol Immunopathol. 1986 Jul;40(1):157-65. doi: 10.1016/0090-1229(86)90081-4.
7
Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.免疫缺陷状态下的腺苷脱氨酶(ADA)及其他酶异常
Birth Defects Orig Artic Ser. 1978;14(6A):73-84.
8
Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).腺苷脱氨酶缺乏症和嘌呤核苷磷酸化酶缺乏症中的淋巴细胞特异性毒性:核苷激酶的可能作用。
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5677-81. doi: 10.1073/pnas.74.12.5677.
9
[Immune insufficiency in enzyme defects of purine metabolism].[嘌呤代谢酶缺陷中的免疫功能不全]
Z Gesamte Inn Med. 1983 Feb 1;38(3):83-9.
10
Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.与腺苷脱氨酶和嘌呤核苷磷酸化酶基因缺陷相关的不同免疫缺陷状态的可能代谢基础。
Proc Natl Acad Sci U S A. 1982 Jun;79(12):3848-52. doi: 10.1073/pnas.79.12.3848.

引用本文的文献

1
Adenosine metabolism and receptors in aging of the skin, musculoskeletal, immune and cardiovascular systems.皮肤、肌肉骨骼、免疫和心血管系统衰老过程中的腺苷代谢与受体
Ageing Res Rev. 2025 Apr;106:102695. doi: 10.1016/j.arr.2025.102695. Epub 2025 Feb 17.
2
Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency.用于辅助未分类严重联合免疫缺陷临床决策的诊断检测
Blood Adv. 2020 Jun 23;4(12):2606-2610. doi: 10.1182/bloodadvances.2020001736.
3
Cultured thymus tissue implantation promotes donor-specific tolerance to allogeneic heart transplants.
体外培养胸腺组织移植促进供者特异性对同种异体心脏移植的免疫耐受。
JCI Insight. 2020 Jun 4;5(11):129983. doi: 10.1172/jci.insight.129983.
4
Synthesis of 2'-deoxy-2'-[18F]fluoro-9-β-D-arabinofuranosylguanine: a novel agent for imaging T-cell activation with PET.2'-脱氧-2'-[18F]氟代-9-β-D-阿拉伯呋喃糖基鸟嘌呤的合成:一种用于正电子发射断层扫描成像 T 细胞激活的新型探针。
Mol Imaging Biol. 2011 Oct;13(5):812-8. doi: 10.1007/s11307-010-0414-x.
5
Themis is a member of a new metazoan gene family and is required for the completion of thymocyte positive selection.Themis是一个新的后生动物基因家族的成员,是胸腺细胞阳性选择完成所必需的。
Nat Immunol. 2009 Aug;10(8):831-9. doi: 10.1038/ni.1769. Epub 2009 Jul 13.
6
Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.磷酸氟达拉滨。一种对慢性淋巴细胞白血病患者和淋巴瘤患者具有显著活性的新型抗癌药物。
Invest New Drugs. 1994;12(2):75-92. doi: 10.1007/BF00874436.
7
Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.腺苷脱氨酶缺乏症患者在酶替代治疗期间淋巴细胞的生化及功能异常
J Clin Invest. 1981 Aug;68(2):413-21. doi: 10.1172/jci110270.
8
Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.具有正常免疫功能的腺苷脱氨酶缺乏症。一种酸性酶突变。
J Clin Invest. 1983 Aug;72(2):483-92. doi: 10.1172/jci110996.
9
Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.嘌呤生成性淋巴细胞毒性:腺苷脱氨酶抑制剂更广泛化疗潜力的线索。
Cancer Chemother Pharmacol. 1983;10(2):73-8. doi: 10.1007/BF00446213.
10
Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.三磷酸脱氧腺苷作为培养的T淋巴母细胞中脱氧鸟苷毒性的介质。
J Clin Invest. 1986 Nov;78(5):1261-9. doi: 10.1172/JCI112710.